TY  - CONF

T1  - Phase 1 Cohort Expansion of Flotetuzumab, a CD123×CD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

JO  - Blood

UR  - https://doi.org/10.1182/blood-2018-99-117085

PY  - 2018/11/29

AU  - Uy GL

AU  - Rettig MP

AU  - Vey N

AU  - Godwin J

AU  - Foster MC

AU  - Rizzieri DA

AU  - Arellano ML

AU  - Topp MS

AU  - Huls G

AU  - Jongen-Lavrencic M

AU  - Martinelli G et al

ED  - 

DO  - DOI: 10.1182/blood-2018-99-117085

PB  - American Society of Hematology

VL  - 132

IS  - Supplement 1

SP  - 764

EP  - 764

Y2  - 2026/02/25

ER  -